← Back to Bristol-Myers Squibb Company
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19574713 | TRIAZOLOPYRIDINYL ETHER LINKED COMPOUNDS AS KINASE INHIBITORS | GAUGER, PAUL RANDALL | 1629 | DP | Non-Final OA | — | Pending | Mar 23, 2026 |
| 19094484 | Kaplan-Meier Digitizer for Automating Kaplan-Meier Curve Analysis | LIU, GORDON G | 2618 | §103 | Non-Final OA | — | Pending | Mar 28, 2025 |
| 19023584 | METHODS TO MANIPULATE QUALITY ATTRIBUTES OF POLYPEPTIDES PRODUCED IN CHO CELLS | FRONDA, CHRISTIAN L | 1652 | §103DP | Non-Final OA | — | Pending | Jan 16, 2025 |
| 18874740 | PERISTALTIC PUMP | KASTURE, DNYANESH G | 3746 | §103 | Final Rejection | 70d | Pending | Dec 13, 2024 |
| 18873229 | TETRAHYDROPYRIDO 3,4-D PYRIMIDINE DERIVATIVES AS KRAS INHIBITORS | COUGHLIN, MATTHEW P | 1626 | §112 | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18857946 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | KRASNOW, NICHOLAS R | 1744 | §103 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18918033 | FRAMEWORK FOR DOCUMENT LAYOUT AND INFORMATION EXTRACTION | HARANDI, SIAMAK | 2662 | DP | Non-Final OA | — | Pending | Oct 16, 2024 |
| 18908888 | CRYSTALLINE FORMS OF A PAR4 INHIBITOR | KIFLE, BRUCK | 1624 | DP | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18847553 | PHARMACEUTICAL COMPOSITIONS FOR IMPROVING ORAL BIOAVAILABILITY | GULLEDGE, BRIAN M | 1699 | §103 | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18817352 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | RAHMANI, NILOOFAR | 1691 | DP | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18839055 | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 | VALENROD, YEVGENY | 1628 | §112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18839079 | SUBSTITUTED IMIDAZOPYRIDINYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 | JACKSON, SHAWQUIA | 1626 | §112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18804699 | SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS | WARD, PAUL V | 1622 | DP | Non-Final OA | — | Pending | Aug 14, 2024 |
| 18718477 | BENZOTHIAZOLE, BENZOISOXAZOLE, AND BENZODIOXOLE ANALOGS AS RXFP1 RECEPTOR AGONISTS | WELLS, LAUREN QUINLAN | — | §102§103§112 | Non-Final OA | — | Pending | Jun 11, 2024 |
| 18694424 | METHODS OF TREATING HAIR-LOSS DISORDERS WITH TYK2 INHIBITORS | RAHMANI, NILOOFAR | 1691 | §102 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18693731 | METHODS OF CONTROLLING THE LEVEL OF DISSOLVED OXYGEN (DO) IN A SOLUTION COMPRISING A RECOMBINANT PROTEIN IN A STORAGE CONTAINER | KIPOUROS, HOLLY MICHAELA | 1799 | §102§103§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18684747 | CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3- (1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE | CHANDRAKUMAR, NIZAL S | 1625 | §103DP | Non-Final OA | — | Pending | Feb 19, 2024 |
| 18435117 | Compounds and Compositions for Selective Degradation of Engineered Proteins | ISMAIL, REHANA | 1625 | §102§103§112 | Non-Final OA | — | Pending | Feb 07, 2024 |
| 18294609 | CELL CULTURE METHODS FOR PRODUCING THERAPEUTIC PROTEINS | METCALF, MATTHEW CURRAN | 1647 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18413928 | MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING | BOWLES, DAVID PAUL | 1654 | §103§112DP | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18579578 | HIGH-AFFINITY SUPRAMOLECULAR POLYMERS FOR BINDING-TRIGGERED ANTIBODY PRECIPITATION AND PURIFICATION | STEPHENS, AMELIA CAROLE | 1645 | §102§103§112DP | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18394005 | LPA1 ANTAGONISTS FOR TREATING INTERSTITIAL LUNG DISEASE | TOWNSLEY, SARA ELIZABETH | 1629 | §112Other | Final Rejection | — | Pending | Dec 22, 2023 |
| 18394402 | LPA1 ANTAGONISTS FOR TREATING INTERSTITIAL LUNG DISEASE | SHTERENGARTS, SAMANTHA L | 1623 | Other | Final Rejection | — | Pending | Dec 22, 2023 |
| 18389891 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | KIM, SEONG JONG | 1621 | §102§103§112DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18531312 | USE OF IMMUNE CHECKPOINT INHIBITORS IN CENTRAL NERVOUS SYSTEMS NEOPLASMS | MOSELEY II, NELSON B | — | §102§103Other | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18504198 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | AULAKH, CHARANJIT | 1621 | Other | Final Rejection | — | Pending | Nov 08, 2023 |
| 18504196 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | AGGARWAL, SAHIL CHANDER | 1623 | §112 | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18041665 | METHOD OF MAKING PROTEIN | BARRON, SEAN C | 1797 | §103§112DP | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18553999 | PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER | COPPINS, JANET L | 1628 | §112Other | Final Rejection | — | Pending | Oct 05, 2023 |
| 18473498 | TREATMENT AND DETECTION METHODS FOR INFLAMMATORY BOWEL DISEASE | KONOPKA, CATHERINE ANNE | 1796 | §102§103§112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18468097 | METHODS OF TREATING TUMOR | TAYLOR, LIA ELAN | 1641 | §103 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18463743 | TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS | AEDER, SEAN E | 1642 | §103Other | Non-Final OA | 44d overdue | Pending | Sep 08, 2023 |
| 18450847 | KRAS INHIBITORS | STOCKTON, LAURA LYNNE | 1626 | §102§112 | Final Rejection | — | Pending | Aug 16, 2023 |
| 18271579 | COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY | DENT, ALANA HARRIS | 1643 | §103 | Final Rejection | 12d | Pending | Jul 10, 2023 |
| 18336889 | COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY | KIM, YUNSOO | 1641 | §103§112 | Final Rejection | 19d overdue | Pending | Jun 16, 2023 |
| 18331831 | KRAS INHIBITORS | COUGHLIN, MATTHEW P | 1626 | §102§103§112 | Non-Final OA | — | Pending | Jun 08, 2023 |
| 18026704 | DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES | WELLS, LAUREN QUINLAN | 1622 | §103 | Final Rejection | 26d overdue | Pending | Mar 16, 2023 |
| 18043544 | CELL LOCALIZATION SIGNATURE AND IMMUNOTHERAPY | SHOEMAKER, ERIC JAMES | 2664 | §102§103 | Non-Final OA | — | Pending | Feb 28, 2023 |
| 18042018 | SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 | MOU, LIYUAN | 1628 | §102§103DP | Final Rejection | 111d overdue | Pending | Feb 17, 2023 |
| 17998521 | DOSING AND ADMINISTRATION OF ACTIVATABLE ANTI-CTLA-4 ANTIBODY | PETERS, ALEC JON | 1641 | §103DP | Final Rejection | 3d overdue | Pending | Nov 11, 2022 |
| 18051936 | MINIATURIZED DYSTROPHINS HAVING SPECTRIN FUSION DOMAINS AND USES THEREOF | MARVICH, MARIA | 1634 | §112 | Non-Final OA | — | Pending | Nov 02, 2022 |
| 17786239 | SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTIVATORS | SAMSELL, RILLA MARIE | 1624 | §112 | Non-Final OA | 132d overdue | Pending | Jun 16, 2022 |
| 17785585 | SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS | MAHLUM, JONATHAN DAVIS | 1625 | §112 | Final Rejection | 132d overdue | Pending | Jun 15, 2022 |
| 17779104 | LABEL-FREE N-GLYCAN QUANTIFICATION METHODS | FRITCHMAN, REBECCA M | 1700 | §103 | Final Rejection | — | Pending | May 23, 2022 |
| 17773425 | SUBSTITUTED PYRAZOLE COMPOUNDS AS TOLL RECEPTOR INHIBITORS | MAHLUM, JONATHAN DAVIS | 1625 | §102§112 | Non-Final OA | — | Pending | Apr 29, 2022 |
| 17772865 | METHODS OF TREATMENT WITH ANTIBODIES AGAINST BCMA AND CD3 | LEE, YIE CHIA | 1642 | §103Other | Final Rejection | 78d | Pending | Apr 28, 2022 |
| 17763614 | COMPOSITE BIOMARKER FOR CANCER THERAPY | AEDER, SEAN E | 1642 | §103 | Final Rejection | 11d overdue | Pending | Mar 24, 2022 |
| 17760692 | DUAL CAPTURE METHOD FOR ANALYSIS OF ANTIBODY-DRUG CONJUGATES | IVICH, FERNANDO NMN | 1678 | §112 | Non-Final OA | 71d overdue | Pending | Mar 15, 2022 |
| 17753657 | PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE INHIBITORS | NGUYEN, NGOC-ANH THI | 1615 | §103 | Final Rejection | — | Pending | Mar 10, 2022 |
| 17639489 | EXTENDED RELEASE DOSAGE FORMS FOR TYK2 INHIBITORS | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | §103§112 | Final Rejection | — | Pending | Mar 01, 2022 |
| 17613904 | METHODS OF MONITORING CELL CULTURE MEDIA | SPANGLER, JOSEPH RANKIN | 1656 | §101§103§112 | Non-Final OA | — | Pending | Nov 23, 2021 |
| 17610634 | AGONISTS OF ROR GAMMAt | BELL, SARA ELIZABETH | 1625 | §102§112 | Non-Final OA | — | Pending | Nov 11, 2021 |
| 17599433 | METHODS OF TREATING TUMOR | BUCHANAN, BAILEY CHEYENNE | 1682 | §103§112 | Non-Final OA | — | Pending | Sep 28, 2021 |
